导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.63% | 130/386 |
| 近一周 | -1.42% | 184/404 |
| 近一月 | -2.63% | 162/404 |
| 近一季 | -12.93% | 308/400 |
| 近半年 | 2.25% | 151/393 |
| 近一年 | 11.18% | 140/381 |
| 近两年 | 78.06% | 121/349 |
| 近三年 | 69.72% | 68/316 |
| 成立以来 | 60.49% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.30% 318/1070 |
35.91% 284/1101 |
- - |
- - |
| 2025 | 46.80% 232/1065 |
5.97% 342/1014 |
7.90% 162/1038 |
32.20% 332/1050 |
-2.88% 602/1065 |
| 2024 | 8.99% 313/1011 |
6.50% 70/960 |
3.34% 147/983 |
1.93% 939/991 |
-2.84% 521/1011 |
| 2023 | -15.08% 524/952 |
-0.98% 667/880 |
-4.09% 458/895 |
-6.71% 407/915 |
-4.15% 418/952 |
| 2022 | -31.53% 656/867 |
-17.83% 418/773 |
7.51% 372/806 |
-11.34% 326/845 |
-12.59% 818/867 |
| 2021 | -8.00% 461/740 |
-7.60% 439/580 |
18.79% 174/659 |
-10.66% 526/704 |
-6.18% 618/740 |
| 2020 | 73.49% 126/554 |
-4.99% 289/419 |
30.75% 120/466 |
16.98% 106/517 |
19.39% 130/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 南方ESG股票C VS. 东吴新产业精选股票A(580008) |